This brand name is authorized in United States
The drug DUVYZAT contains one active pharmaceutical ingredient (API):
1
Givinostat
UNII 5P60F84FBH - GIVINOSTAT
|
Givinostat is a histone deacetylase inhibitor. The precise mechanism by which givinostat exerts its effect in patients with Duchenne muscular dystrophy (DMD) is unknown. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
DUVYZAT Oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
M09AX14 | M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AX Other drugs for disorders of the musculo-skeletal system | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: US | FDA, National Drug Code | Identifier(s): 11797-110 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.